LONG and Holding.
sorry for those whom lost money over this bogus report, but thanks for cheap shares
bet on that.
Deutsche Bank at $ 62 Before earning. Wii raise After earnings.,
or miss the run up and earnings upgrades
Seeking Alpha By: Brian Nichols 10/14/13
Pimavanserin: The Most Underestimated Blockbuster In Biotechnology
The bottom line is that as time passes, expect estimates to rise quickly for pima, which will then drive the valuation for Acadia. The current market potential for pima simply does not reflect the valuation of the PDP indication let alone ADP and Schzo. Therefore, unprecedented gains are likely. And for those of you hoping for a buyout or a substantial partnership, I'd cross your fingers and pray that management does not yet
entertain such offers. Due to the disruptive nature of pima, many leading pharmaceutical companies are going to lose billions because of pima, which means Acadia is likely already speaking with or is being assessed by a handful of large companies. However, this is a company that simply has too much upside fora 100% premium right now, and over the next year as peak sales estimate rise, you will see that any price under $50 is cheap
added more today, knew this was a joke in the $20,, will see 4100 on this one.
Seen this 1,000 times in trading. Will be back over $3 by Monday. Great buy opportunity.